Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. antibiotic resistant
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Antibiotic Resistant Articles & Analysis

104 news found

Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Due to their unique mechanism of action, AMPs are increasingly seen as promising alternatives to traditional antibiotics, especially as antibiotic resistance continues to emerge and spread globally. ...

ByProfacgen


Ace Therapeutics Announces Vaccine Development Services Against Superbugs

Ace Therapeutics Announces Vaccine Development Services Against Superbugs

Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. With the rise of antibiotic-resistant bacteria posing a significant threat to global public health, Ace Therapeutics announces its new ...

ByAce Therapeutics


Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

The rise of antibiotic-resistant bacteria has driven renewed interest in alternative treatments, including phage therapy. A recent study by Yang, F., et al (2024) explores the potential of bacteriophage therapy for treating multi-drug resistant Mycobacterium tuberculosis (Mtb) infections using humanized mouse models. ...

BySCIREQ - an emka TECHNOLOGIES Company


CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights

CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights

Agricultural Genomics: Improving crop yields and developing disease-resistant plant varieties. 4. Microbial Genomics: Studying pathogen evolution and antibiotic resistance mechanisms. ...

ByCD Genomics


Infection Control Resources to Mitigate Exposure Risks to Acinetobacter and Other Environmental Pathogens

Infection Control Resources to Mitigate Exposure Risks to Acinetobacter and Other Environmental Pathogens

“Even with our recent emphasis on antibiotic stewardship, Multidrug-resistant Organisms (MDRO) or so-called ‘Superbugs’ are presenting new challenges to our healthcare system due to what amounts to microscopic selective breeding. One such example is Multidrug-resistant Acinetobacter (MDR-A).” Mr. Denis goes on to say, ...

ByCochrane & Associates, LLC


CD Formulation Leads the Way in Antiserum Preparation

CD Formulation Leads the Way in Antiserum Preparation

Antibacterial Serum Preparation Bacterial infections remain a significant concern globally, and the emergence of antibiotic-resistant strains has heightened this challenge. CD Formulation addresses this urgent issue with its antibacterial serum preparation services. ...

ByCD Formulation


Infection Control Resources to Safeguard Patients from Vancomycin-Resistant Enterococci and Other Pathogens

Infection Control Resources to Safeguard Patients from Vancomycin-Resistant Enterococci and Other Pathogens

The Centers for Disease Control and Prevention (CDC) warns these bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat those infections. Vancomycin-resistant enterococci (VRE) is the name for the bacteria resistant to the antibiotic known as vancomycin. When the CDC released the 2019 ...

ByCochrane & Associates, LLC


Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

Their newest production discusses vancomycin-resistant enterococci, commonly referred to as VRE, which are bacteria that can cause various healthcare-associated infections (HAIs). “In the CDC’s 2019 Antibiotic Resistance Threats in the United States report, VRE was listed as a serious threat,” said Paul Cochrane, President of ...

ByCochrane & Associates, LLC


MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research

MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research

Plasmids are important carriers for the rapid adaptation of microbial populations to environmental changes, and plasmid-mediated gene transfer is critical for the spread of Antibiotic Resistance Genes (ARGs). Plasmids are transmissible between host cells, leading to the rapid dissemination of their accessory genes through bacterial communities. The Food Safety ...

ByCD Genomics


7 December 2022 - FDA/CDC highlight need for infection preventions

7 December 2022 - FDA/CDC highlight need for infection preventions

Dr Michael Craig, (Director of Antimicrobial Resistance) at the US CDC stated: “Decolonization is something that is very important to us at CDC and something that we think really holds a lot of potential in terms of saving lives and importantly addressing the challenges of antimicrobial resistance that we face, not only in the United States but around ...

ByDestiny Pharma plc


Lumen Bioscience Awarded $3.6 Million by U.S. Army to Advance Low-cost, Scalable Preventative for Antibiotic-Resistant Infections

Lumen Bioscience Awarded $3.6 Million by U.S. Army to Advance Low-cost, Scalable Preventative for Antibiotic-Resistant Infections

This preventative approach will allow Lumen to develop an inexpensive, biologic drug cocktail against the most frequent, multi-drug resistant infecting pathogens. The therapeutic product would be administered and be designed to mitigate risks of antibiotic-resistant infections in resource constrained settings such as battlefield medicine and ...

ByLumen Bioscience, Inc.


A project led by Vaxdyn receives funding from Next Generation EU Funds

A project led by Vaxdyn receives funding from Next Generation EU Funds

First, to raise specific immunity against one of the most important antibiotic-resistant bacteria in humans populations at hjgh-risk of development of antibiotic-resistant infections. ...

ByVaxdyn, S. L.


Ondine’s photodisinfection kills ESKAPE pathogens

Ondine’s photodisinfection kills ESKAPE pathogens

(LON: OBI), this week presented an in vitro study at the World Anti-Microbial Resistance Congress, in Maryland, USA on the effectiveness of its photodisinfection technology against the group of highly infectious and antibiotic-resistant bacteria known as ESKAPE ...

ByOndine Biomedical Inc


Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Several years ago, the Centers for Disease Control and Prevention (CDC) announced it was establishing the Antibiotic Resistance Laboratory Network (AR Lab Network) in Puerto Rico and all 50 states. It was designed to help detect new forms of drug resistance as novel fungal threats emerge. Specifically mentioned in the announcement was Candida ...

ByCochrane & Associates, LLC


Infection Control Resources for Candida auris and Other Superbugs

Infection Control Resources for Candida auris and Other Superbugs

The Centers for Disease Control and Prevention (CDC) established the Antibiotic Resistance Laboratory Network (AR Lab Network) in all 50 states back in 2016. ...

ByCochrane & Associates, LLC


Accelerate Diagnostics Announces Launch Of Accelerate Arc Module and BC Kit

Accelerate Diagnostics Announces Launch Of Accelerate Arc Module and BC Kit

(NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the launch of the Accelerate Arc system, comprised of the Arc Module and BC Kit, an automated path to rapid and accurate microbial identification for positive blood cultures. ...

ByAccelerate Diagnostics, Inc.


Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

Owing to the increasing concerns about the abuse of antibiotics and the emergence of antibiotic-resistant microorganisms, academia and pharmaceutical companies as well as many biochemical suppliers like BOC Sciences have invested much energy in AMP development. ...

ByBOC Sciences


Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

Clinicians therefore utilize presumptive treatment, or prescribing treatment for a suspected infection without the benefit of diagnostic results, which can lead to incorrect treatment, under-treatment, or over-treatment which contributes to societal antibiotic resistance. “Sexually transmitted infections are three things: often asymptomatic, can be harmful ...

ByVisby Medical, Inc.


Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SER-155 is a cultivated investigational microbiome therapeutic rationally designed to improve clinical outcomes in patients undergoing HSCT by restoring colonization resistance to pathobionts, promoting epithelial barrier integrity, and reducing colonic inflammation. ...

BySeres Therapeutics, Inc.


OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero results combined with antibiotic ...

ByOpGen, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT